What Researchers Did
The authors wrote a review describing how oxygen relates to wound healing and a topical oxygen-carrying skin product made for use after aesthetic skin procedures.
What They Found
This review article describes a topical perfluorocarbon emulsion, made of perfluorodecalin, water, plant-derived emulsifiers and a preservative, that is designed for use in dermatology, and the abstract reports no patient results for it. The abstract states that wounds are often low in oxygen and that the outer layers of skin get their oxygen almost entirely from the air. It says perfluorocarbon preparations containing 2% of these compounds can absorb up to seven times more oxygen than water at 37 degrees C, which it gives as a general property of such preparations and not as a measurement of this product. The product is designed to be applied 2 to 4 times daily after skin rejuvenation procedures, and the abstract says it reduces the incidence of post-procedure complications, without giving numbers.
What This Means for Canadian Patients
The abstract says hyperbaric oxygen therapy is beneficial for treating nonhealing wounds such as diabetic ulcers and has been used to speed recovery after aesthetic procedures, but it is not suitable for home use. The topical emulsion is described as well suited to patient application after energy-based aesthetic procedures. The abstract reports no trial data on the emulsion, so it does not show how well the product works for any individual patient.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract gives no sample size, comparison group or measured results for the emulsion, so its claim of fewer post-procedure complications cannot be checked from the abstract alone.